Related Experiment Video
Updated: Jun 6, 2026

The NeuroStar TMS Device: Conducting the FDA Approved Protocol for Treatment of Depression
Published on: November 12, 2010
Continuing antidepressants or not: Evaluating the potential benefits and harms
Katharine A Wallis1, Joanna Moncrieff2, Mark A Horowitz3
1BA, BSc, GDPsych, MSc, MBBS, PhD, Associate Professor of Psychiatry, Critical and Ethical Mental Health Research Group, Adelaide University, Adelaide, SA; Clinical Research Fellow, Research and Development Department, North East London NHS Foundation Trust, Ilford, UK; Visiting Lecturer in Psychopharmacology, Institute of Pharmaceutical Sciences, King@s College London, London, UK.
Background:
Many Australians use antidepressants for longer periods, and for less severe conditions, than current guidelines recommend. Recent commentary has explored the rationale for stopping antidepressants, but overlooked flaws in the evidence for continuing antidepressants long- term.
Objective:
To critically appraise the evidence for continuing antidepressants long-term (>12 months).
Discussion:
The evidence for long-term use of antidepressants stems primarily from discontinuation studies in which people taking antidepressants are randomised to either stop or continue. These studies do not distinguish withdrawal symptoms from relapse. Worsening mood/anxiety in the discontinued group is interpreted as relapse and findings interpreted as evidence that long-term therapy prevents relapse, ignoring the possibility that the apparent benefits of continuing antidepressants might lie in suppressing withdrawal symptoms. Due to the lack of robust evidence for benefit, and established evidence showing harm with long-term use, antidepressant treatment should be regularly reviewed with shared decision making about whether to continue or stop.
Related Concept Videos
Antidepressant Drugs: Overview
Antidepressant Drugs: MAOIs and Other Agents
Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Electroconvulsive Therapy
Drug Therapy
Antianxiety Medications
Psychosis: Goals of Pharmacotherapy
